Analyst EPS Estimates Coverage: Bristol-Myers Squibb Company (BMY)

Maricruz Casares
Febrero 15, 2018

In addition to the $1.85 billion in cash, Bristol could pay Nektar $1.78 billion more, depending on the drugs' progress. Trading volume for Bristol-Myers Squibb Company was 7.41 Million in its previous trading session. About 369,775 shares traded. It has underperformed by 39.89% the S&P500. Scheer Rowlett & Associates Investment Management Ltd bought 299,388 shares as the company's stock declined 12.05% while stock markets rallied. At the moment, the company has a debt-to-equity ratio of 0.57, a current ratio of 1.60, and a quick ratio of 1.50. Navient Corporation (NAVI) has a market cap of $3.55 billion and over the last 12 months, Navient Corporation (NASDAQ:NAVI) has gone weaker by -12.97%. The stock increased 1.21% or $0.77 during the last trading session, reaching $64.64. About 7.52 million shares traded or 11.87% up from the average. (NYSE:HD) has risen 18.65% since February 14, 2017 and is uptrending. It has outperformed by 29.15% the S&P500.

Among 33 analysts covering The Home Depot Inc. (NASDAQ:PRAA) to report earnings on February, 27.

Davide Leone & Partners Investment Company Llp decreased its stake in Bristol Myers Squibb Co (Call) (BMY) by 0.8% based on its latest 2017Q3 regulatory filing with the SEC. Across all cohorts, the median age of patients was 61 years, 68.4% were treated in the frontline setting, and most had an ECOG performance status of 0 (65.8%).

The company is expected to report earnings of $0.84 a share for the next quarter. Strong Sell. Investors might also notice that two months ago the Buy recommendations (0) were less than Sell recommendations (0). Portfolio Recovery Associates had 17 analyst reports since October 14, 2015 according to SRatingsIntel. On Thursday, September 7 the stock rating was initiated by Berenberg with "Hold". Piper Jaffray has "Hold" rating and $60.0 target. The stock of Micron Technology, Inc. The firm has "Buy" rating by Guggenheim given on Wednesday, December 2. As per Friday, January 15, the company rating was maintained by Stifel Nicolaus. The rating was downgraded by IBC on Friday, August 26 to "Sector Performer". If the combination strategy is successful, the billions of dollars in new cancer immunotherapy revenue that will be generated will more than justify the steep cost of buying into NKTR-214.

Investors sentiment decreased to 1.22 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. It increased, as 59 investors sold HD shares while 562 reduced holdings. Shares of NAVI have uptrended 11.7% in the past three months, while the S&P 500 has moved 8.67% in that time. 9,340 shares were sold by Caldarella Joseph C, worth $560,400. Outfitter Advsrs Limited reported 210,197 shares. Pnc Services Group holds 1.43M shares. Gmt invested in 0.34% or 531,141 shares. Nomura reported 506,907 shares. Anchor Capital Advisors Lc owns 21,320 shares. 77,918 were reported by Envestnet Asset Mngmt. Blb&B Ltd Liability Corp invested 0.06% of its portfolio in The Home Depot, Inc. Koshinski Asset Mngmt owns 6,156 shares or 0.11% of their U.S. portfolio. It increased, as 62 investors sold BMY shares while 519 reduced holdings. Its down 0.09, from 0.87 in 2017Q2. Leerink Swann maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Monday, October 23. During the same quarter in the previous year, the firm earned $0.63 earnings per share. equities research analysts forecast that Bristol-Myers Squibb Co will post 3.22 earnings per share for the current fiscal year. For shareholders, given the total diluted outstanding shares of 1.64 billion, this means overall earnings per share of -1.42. Bb&T Secs Ltd Liability Com invested in 564,006 shares or 0.49% of the stock. 15,230 were accumulated by Kistler.

More news: Here's The Handsome Record Rohit Sharma Broke In The 5th ODI

Bristol-Myers Squibb Co (BMY) opened at $63.87 on Wednesday. Wealthtrust Fairport Limited Co owns 6,377 shares for 0.04% of their portfolio. Chem National Bank & Trust reported 9,907 shares stake. Banque Pictet Cie Sa owns 20,850 shares. Tocqueville Asset Management Lp holds 0.49% or 662,822 shares. State Treasurer State Of Michigan stated it has 764,317 shares. OPHT's SI was 1.30 million shares in February as released by FINRA. Florida-based Raymond James Financial Serv Advsrs has invested 0.18% in Bristol-Myers Squibb Company (NYSE:BMY).

Since October 30, 2017, it had 0 insider buys, and 1 sale for $145,884 activity. 4,000 shares were sold by Henderson Gregory N., worth $366,080 on Friday, January 5. 4,000 shares were bought by Samuels Theodore R. II, worth $249,187. Therefore 50% are positive. The price/earnings ratio (P/E) is 107.60 and the forward P/E ratio stands at 16.19.

The company's distance from 52-week high price is -3.37% and the current price is 23.88% away from 52-week low price. Cowen & Co maintained the stock with "Hold" rating in Monday, August 14 report. The firm earned "Buy" rating on Monday, November 6 by BMO Capital Markets. The company was maintained on Friday, August 19 by UBS.

On this news, Bristol-Myers's share price fell $5.62, or 10.1%, to close at $49.81 on October 10, 2016. Robert W. Baird maintained it with "Buy" rating and $195.0 target in Thursday, November 30 report. BMO Capital Markets maintained it with "Underperform" rating and $51 target in Tuesday, February 6 report.

Otros informes por

Discuta este artículo

SIGUE NUESTRO PERIÓDICO